Skip to content
Tenfell
Awarded contract
Published 28 Nov 2024

NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024

NHS England · London

Key facts

Awarded
28 Oct 2024
Contract starts
01 Nov 2024
Contract ends
31 Oct 2026
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 13 suppliers

SupplierValue
Dr Reddy's Laboratories (UK) Ltd—
Janssen-Cilag Ltd—
Abbvie Ltd—
Gilead Sciences Limited—
Merck Sharpe & Dohme (UK) Limited—
Mylan—
Amarox Limited—
ViiV Healthcare UK Ltd—
Lupin Healthcare UK Ltd—
Mawdsley Brooks & Co Ltd—
Macleods Pharma UK Limited—
MSN Laboratories Europe Limited—
Milpharm Ltd/aurobinbdo Primary—

Description

Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024 Offer reference number: CM/PHS/24/5709 Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.